{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T08:08:45Z","timestamp":1753862925509,"version":"3.41.2"},"reference-count":33,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cochrane Evidence Synthesis and Methods"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Benign conditions of the prostate include benign prostatic enlargement and prostatitis, which constitute an important cause of morbidity in men.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>We aimed to generate a list of priority topics of interest to our external stakeholders within our editorial scope.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Following Cochrane's guidance, we developed a tiered approach for consulting internal and external stakeholders, including members from Urological societies. First, we analyzed our portfolio, including different impact measurements, to assess the need for updates. Then, following criteria related to the feasibility, novelty and relevance of prospective topics for evidence synthesis, we narrowed the list to a suite of titles for updates or new reviews.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twelve editors provided initial feedback as to what the priorities were for updating existing reviews and for new reviews in our portfolio. The editors identified gaps in our portfolio, mainly covering new treatments for benign prostatic hyperplasia. Then we consulted external stakeholders obtaining 30 responses from 14 countries. These stakeholders provided additional information about the relative importance of existing topics and suggested new ones. We identified that many of the latter were already covered in our portfolio, highlighting gaps in their dissemination. Finally, we narrowed down four priority topics that the editorial group will take forward and two additional topics that might need other considerations before being commissioned.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Following Cochrane's guidance on priority setting, we identified topics relevant to our editors and external stakeholders by analysing our portfolio and two rounds of surveys. Moreover, we identified opportunities for disseminating existing reviews. Further evaluation is needed of the following up commissioning process for priority reviews.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cesm.12002","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T10:29:16Z","timestamp":1679912956000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quick prioritization of Cochrane reviews on benign conditions of the prostate"],"prefix":"10.1002","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0411-899X","authenticated-orcid":false,"given":"Juan V. A.","family":"Franco","sequence":"first","affiliation":[{"name":"Institute of General Practice Medical Faculty of the Heinrich\u2010Heine\u2010University D\u00fcsseldorf  D\u00fcsseldorf Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae H.","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Urology Yonsei University Wonju College of Medicine  Wonju South Korea"},{"name":"Centre of Evidence\u2010Based Medicine, Institute of Convergence Science Yonsei University  Seoul South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Dahm","sequence":"additional","affiliation":[{"name":"Minneapolis VAMC, Urology Section and Department of Urology University of Minnesota  Minneapolis Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"key":"e_1_2_11_2_1","first-page":"467","article-title":"Methods for setting priorities in systematic reviews","volume":"66","author":"Tugwell P","year":"2013","journal-title":"JCE"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12961-016-0107-2"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/1478-4505-7-S1-S3"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62229-1"},{"key":"e_1_2_11_6_1","unstructured":"IARC. Global Cancer Observatory.2020. Accessed September 4 2021.https:\/\/gco.iarc.fr\/"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06628-8"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12745"},{"key":"e_1_2_11_9_1","unstructured":"CIE\u201011. WHO.2019. Accessed September 4 2021.https:\/\/icd.who.int\/es"},{"key":"e_1_2_11_10_1","first-page":"67","article-title":"A common framework of steps and criteria for prioritizing topics for evidence syntheses: a systematic review","volume":"120","author":"Fadlallah R","year":"2020","journal-title":"JCE"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-019-0889-3"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1590\/s1677-5538.ibju.2016.0047"},{"key":"e_1_2_11_13_1","unstructured":"FrancoJVA DahmP JungJH LaneR.Cochrane Urology Prioritization.2020.doi:10.17605\/OSF.IO\/49SCM"},{"key":"e_1_2_11_14_1","unstructured":"Officer CE. Guidance for Cochrane Review priority setting. Accessed June 19 2022.https:\/\/training.cochrane.org\/online-learning\/knowledge-translation\/priority-setting\/guidance-cochrane-review-priority-setting"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015500"},{"key":"e_1_2_11_16_1","first-page":"99","article-title":"Priority setting for Cochrane Review Groups","volume":"110","author":"Del Mar C","year":"2019","journal-title":"JCE"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019481"},{"key":"e_1_2_11_18_1","first-page":"63","article-title":"Cochrane acute respiratory infections group's stakeholder engagement project identified systematic review priority areas","volume":"102","author":"Scott AM","year":"2018","journal-title":"JCE"},{"volume-title":"Designing Clinical Research","year":"2013","author":"Hulley SB","key":"e_1_2_11_19_1"},{"key":"e_1_2_11_20_1","article-title":"Anticholinergics combined with alpha\u2010blockers for treating lower urinary tract symptoms related to benign prostatic obstruction","volume":"2","author":"Pang R","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_21_1","article-title":"Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia","author":"Franco JVA","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12961-019-0444-z"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14183"},{"key":"e_1_2_11_24_1","article-title":"Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia","volume":"3","author":"Jung JH","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_25_1","article-title":"Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia","volume":"3","author":"Kang TW","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_26_1","article-title":"Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia","volume":"5","author":"Jung JH","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_27_1","article-title":"Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta\u2010analysis","author":"Franco JVA","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_28_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069002","article-title":"What is the role of minimally invasive surgical treatments for benign prostatic enlargement?","volume":"377","author":"Franco JVA","year":"2022","journal-title":"BMJ"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15653"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.210115"},{"key":"e_1_2_11_31_1","first-page":"110","article-title":"Copublication improved the dissemination of Cochrane reviews and benefited copublishing journals: a retrospective cohort study","volume":"149","author":"Zhu L","year":"2022","journal-title":"JCE"},{"key":"e_1_2_11_32_1","unstructured":"Cochrane.KT framework and implementation; 2017. Accessed January\u00a019 2023.https:\/\/community.cochrane.org\/review-production\/knowledge-translation\/kt-framework-and-implementation"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12961-020-00604-x"},{"volume-title":"Cochrane Database of Systematic Reviews 2020 Impact Report","year":"2021","author":"Soares\u2010Weiser K","key":"e_1_2_11_34_1"}],"container-title":["Cochrane Evidence Synthesis and Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cesm.12002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T18:44:22Z","timestamp":1744224262000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cesm.12002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1002\/cesm.12002"],"URL":"https:\/\/doi.org\/10.1002\/cesm.12002","archive":["Portico"],"relation":{},"ISSN":["2832-9023","2832-9023"],"issn-type":[{"type":"print","value":"2832-9023"},{"type":"electronic","value":"2832-9023"}],"subject":[],"published":{"date-parts":[[2023,3,27]]},"assertion":[{"value":"2022-11-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e12002"}}